Anemia

Most CKD Patients With Anemia Show Limited Response to Oral Iron

Most CKD Patients With Anemia Show Limited Response to Oral Iron

By

In a 52-week trial, more than half of nondialysis-dependent chronic kidney disease patients with anemia treated with oral iron had no rise in their hemoglobin levels.

Anemia in Dialysis Patients Linked With Hemorrhagic Stroke

Anemia in Dialysis Patients Linked With Hemorrhagic Stroke

By

Patients with hemoglobin values of 9.7 g/dL or below had more than double the risk for hemorrhagic stroke compared with patients with hemoglobin values of 11.2 g/dL or above.

CERA Effective for Pediatric Hemodialysis Patients With Anemia

CERA Effective for Pediatric Hemodialysis Patients With Anemia

By

The safety profile of CERA is similar for children as for adults.

Lower IV Iron Dosing in Anemic Dialysis Patients May Be More Effective

Lower IV Iron Dosing in Anemic Dialysis Patients May Be More Effective

By

To support ESA therapy, IV iron at doses below 300 mg/month may be most effective for the average hemodialysis patient, according to an observational study.

Ceruloplasmin a Possible Marker of CKD in Sickle Cell Anemia

Ceruloplasmin a Possible Marker of CKD in Sickle Cell Anemia

Urinary ceruloplamin has potential to be a chronic kidney disease biomarker for patients with sickle cell anemia.

Darbepoetin Alfa Safe for Pediatric CKD Patients With Anemia

Darbepoetin Alfa Safe for Pediatric CKD Patients With Anemia

By

Researchers tested once weekly and biweekly administration of darbepoetin alfa in children aged 1 to 18 years not previously treated with an erythropoiesis-stimulating agent.

Residual Renal Function Not Linked to ESA Requirements

Residual Renal Function Not Linked to ESA Requirements

By

Researchers find no significant difference in the median erythropoietin resistance index between patients with versus without residual renal function.

Case: Treating Iron Deficiency Anemia in a Heart Failure Patient

Case: Treating Iron Deficiency Anemia in a Heart Failure Patient

To shed light on the often-challenging management of this common condition, a case of a hypothetical patient was presented to a doctor who specializes in advanced heart failure and transplant cardiology.

High ESA and Iron Doses Up CVD, Death Risk in Hemodialysis Patients

High ESA and Iron Doses Up CVD, Death Risk in Hemodialysis Patients

By

High doses of iron are associated with a significantly higher risk of cardiovascular disease, regardless of the dose of erythropoiesis-stimulating agent.

Ferric Citrate Approved for Anemia in CKD Patients

Ferric Citrate Approved for Anemia in CKD Patients

By

Study results show that the phosphate binder was superior to placebo in raising hemoglobin levels in non-dialysis-dependent CKD patients with iron-deficiency anemia.

IV Iron, Erythropoietin Equally Effective for Anemia in HD Patients

IV Iron, Erythropoietin Equally Effective for Anemia in HD Patients

By

Intravenous iron and erythropoietin produced a similar hemoglobin response among hemodialysis patients with moderate anemia.

Higher Hemoglobin Levels, Better Graft Function Linked

Higher Hemoglobin Levels, Better Graft Function Linked

By

The group targeting higher hemoglobin values experienced less decline in graft function.

Predialysis Anemia Treatment May Cut Mortality After HD Initiation

Predialysis Anemia Treatment May Cut Mortality After HD Initiation

By

HD patients with untreated or ineffectively treated anemia prior to dialysis initiation were more likely to die than those who had consistently well-treated anemia.

Anemia Raises ESRD Risk in Patients With Chronic Kidney Disease

Anemia Raises ESRD Risk in Patients With Chronic Kidney Disease

By

In a study, end-stage renal disease was 31% more likely to develop in CKD patients with versus without anemia.

Anemia Linked to High FGF23 Levels in CKD Patients

Anemia Linked to High FGF23 Levels in CKD Patients

By

CKD patients in the 3rd and 4th quartiles of c-terminal serum fibroblast growth factor 23 had a 74% and 73% higher risk for anemia compared with those in the 1st quartile.

Anemia Risk Factors in Diabetic Nephropathy Patients Identified

Anemia Risk Factors in Diabetic Nephropathy Patients Identified

By

Proteinuria and renin-angiotensin-aldosterone system inhibitors are independently associated with a significant 6-fold increased odds for anemia in patients with diabetic nephropathy.

Hereditary Hemochromatosis Patients Can Be Blood Donors

Hereditary Hemochromatosis Patients Can Be Blood Donors

No data to suggest that nonvoluntary nature of donations compromises safety of blood products.

Long-Acting ESAs Can Save Time, Costs

Long-Acting ESAs Can Save Time, Costs

Findings based upon time costs of preparation and administration per patient.

Daily Vitamin D Does Not Improve or Prevent Anemia

Daily Vitamin D Does Not Improve or Prevent Anemia

By

In a randomized study of patients with heart failure, including some with concurrent chronic kidney disease, patients who received vitamin D supplements or placebo had similar changes in hemoglobin levels over 36 months.

Anemia Common After Bariatric Surgery

Anemia Common After Bariatric Surgery

Anemia much more common among patients who did not have close follow-up with weight-loss surgeon

Patients Weigh Anemia Management Options

Patients Weigh Anemia Management Options

By

In a survey, hemodialysis patients were willing to accept medication risks to avoid red blood cell transfusion.

Anemia by Itself Linked With Early Death

Anemia by Itself Linked With Early Death

By

Study of Japanese individuals showed that anemia increased mortality risk even in the absence of chronic kidney disease.

Iron-based Binder Improves Phosphorus Levels in Dialysis Patients

Iron-based Binder Improves Phosphorus Levels in Dialysis Patients

By

The proportion of patients with serum phosphorus levels within target range rose from 22% to 65% within 6 months of starting ferric citrate treatment.

Ferritin Spike Soon After Hemodialysis Initiation Ups Mortality Risk

Ferritin Spike Soon After Hemodialysis Initiation Ups Mortality Risk

By

Up to a 49% higher risk of death observed in patients who had a 400 ng/mL increase in serum ferritin from baseline values compared with patients who had relatively stable ferritin levels.

Optimal Iron Status for Hemodialysis Patients Reported

Optimal Iron Status for Hemodialysis Patients Reported

By

Japanese researchers conclude that a serum ferritin level below 90 ng/mL and TSAT of 20% or higher was optimal for achieving a hemoglobin level of 10 g/dL or higher.

Low Hemoglobin, Low SEVR Linked in Chronic Kidney Disease

Low Hemoglobin, Low SEVR Linked in Chronic Kidney Disease

By

Researchers used pulse wave analysis to measure subendocardial viability ratio, a measure of myocardial perfusion, and its association with hemoglobin.

RBC Distribution Width, Dialysis Patient Mortality Linked

RBC Distribution Width, Dialysis Patient Mortality Linked

By

As red blood cell distribution width increases, so does the risk of death from any cause.

Non-Dialysis CKD Patients With Anemia Have More CVD, Worse QoL

Non-Dialysis CKD Patients With Anemia Have More CVD, Worse QoL

By

Anemic patients were 41% and 80% more likely to have coronary artery disease and peripheral artery disease than non-anemic patients.

New Review Highlights Iron Deficiency Anemia in CKD

New Review Highlights Iron Deficiency Anemia in CKD

By

Intravenous iron should be strongly considered for patients treated with ESAs or hemodialysis, according to reviewers.

Low Testosterone Tied to Anemia Risk in Men With Type 2 Diabetes

Low Testosterone Tied to Anemia Risk in Men With Type 2 Diabetes

In type 2 diabetic male patients, a low testosterone level was found to be associated with anemia. These findings are consistent with previous reports.

Sign Up for Free e-newsletters